🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

ArriVent BioPharma, Inc. Common Stock

ArriVent BioPharma, Inc. Common Stock logo
Market Cap: Medium
Employees: Lowest

Furmonertinib

Arri Vent Bio Pharma, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing medicines for unmet medical needs in cancer, particularly NSCLC and other solid tumors. It develops Furmonertinib, a selective tyrosine kinase inhibitor. The company is based in Newtown Square, Pennsylvania and has strategic partnerships for advancing its pipeline.

Tags: NSCLC, biopharmaceutical, cancer treatment, clinical trials, solid tumors

Website

About | About | About | Contact | Careers | Careers | Management

Symbol: AVBP

Recent Price: $26.95

Industry: Biotechnology

CEO: Dr. Zhengbin Yao Ph.D.

Sector: Healthcare

Employees: 40

Address: 18 Campus Boulevard, Newtown Square, null 19073

Phone: 628-277-4836

Last updated: 2024-12-31